Medtronic PLC (MDT) Peer Comparison
$91.48
$-0.55
(-0.59%)
As on 27-Aug-2026 11:42EDT
Market cap
$118,142 Mln
Revenue (TTM)
$36,364 Mln
P/E Ratio
25.2
P/B Ratio
2.4
Div. Yield
3 %
Edit
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
118,142 | 44,907 | 40,697 | 32,953 | 14,865 |
Revenue ($ Mln) |
36,364 | 7,232 | 3,319 | 5,653 | 4,231 |
Net Profit ($ Mln) |
4,800.00 | 1,414.00 | 941.65 | 1,523.29 | 235.80 |
Net Margin (%) |
13.20 | 19.55 | 28.37 | 26.94 | 5.57 |
RoE (%) |
9.85 | 20.40 | 13.13 | 24.27 | 2.86 |
Price to Earnings |
25.22 | 31.36 | 44.42 | 22.11 | 64.59 |
Price-To-Book |
2.44 | 6.20 | 5.58 | 5.05 | 1.80 |
Income Statement ($ Mln)
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
36,364.00 | -- | 3,195.31 | 5,653.44 | -- |
|
Cost of Revenue
|
12,721.00 | -- | 782.02 | 2,195.77 | -- |
|
Gross Profit
|
23,643.00 | -- | 2,413.29 | 3,457.68 | -- |
|
Operating Expenses
|
17,179.00 | -- | 1,496.92 | 1,565.03 | -- |
|
Operating Profit (EBIT)
|
6,467.00 | -- | 916.37 | 1,892.65 | -- |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
6,136.00 | -- | 1,194.51 | 1,919.42 | -- |
|
Provision for Tax
|
1,299.00 | -- | 285.60 | 396.12 | -- |
|
Profit after Tax (Net Income)
|
4,800.00 | -- | 908.91 | 1,523.29 | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
49,463.00 | -- | 7,214.75 | 6,585.39 | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
31,298.00 | -- | 127.54 | 985.45 | -- |
|
Current Liabilities
|
11,658.00 | -- | 1,637.06 | 1,395.11 | -- |
|
Total Liabilities
|
93,028.00 | -- | 8,979.34 | 8,965.95 | -- |
Assets ($ Mln)
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68,240.00 | -- | 981.71 | 4,641.21 | -- |
|
Current Assets
|
24,787.00 | -- | 7,997.63 | 4,324.74 | -- |
|
Total Assets
|
93,028.00 | -- | 8,979.34 | 8,965.95 | -- |
|
Total Debt*
|
27,961.00 | -- | 95.86 | 825.92 | -- |
|
Net Current Assets
|
13,129.00 | -- | 6,360.57 | -- | -- |
Cashflow ($ Mln)
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
7,330.00 | -- | 1,415.23 | 1,805.83 | -- |
|
Cash Flow from Investing Activities
|
-2,934.00 | -- | -1,104.36 | -545.20 | -- |
|
Cash from Financing Activities
|
-4,751.00 | -- | -9.33 | -1,007.03 | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.24 | -- | 13.75 | 21.41 | -- |
|
ROE (%)
|
9.85 | -- | 13.93 | 24.27 | -- |
|
ROA (%)
|
5.20 | -- | 11.14 | 17.77 | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
13.20 | -- | 28.44 | 26.94 | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.08 | -- | 0.16 | 0.10 | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
2.96 | -- | 27.27 | 8.75 | -- |
|
EPS Growth (%)
|
-- | -- | -- | 0.10 | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | 18.55 | -- |
|
Price / Book Value
|
-- | -- | -- | 4.29 | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
1.91 | -- | -5.19 | 12.86 | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.57 | -- | 0.01 | 0.13 | -- |
|
Short term debt to equity ratio
|
0.04 | -- | 0.00 | 0.04 | -- |
|
Current Ratio
|
2.13 | -- | 4.89 | 3.10 | -- |
|
Quick Ratio
|
1.62 | -- | -- | 2.42 | -- |
|
Interest Coverage
|
9.58 | -- | -- | 67.12 | -- |
Operating Efficiency Ratios
| Medtronic PLC (MDT) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | ResMed (RMD) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.27 | -- | 41.01 | 18.33 | -- |
|
Asset Turnover
|
0.39 | -- | 0.39 | 0.66 | -- |
|
Receivable days
|
66.08 | -- | 135.31 | 65.48 | -- |
|
Inventory Days
|
164.05 | -- | -- | 155.82 | -- |
|
Payable days
|
73.12 | -- | 15.90 | 48.83 | -- |
|
Cash Conversion Cycle
|
157.01 | -- | -- | 172.47 | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
